http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0194944-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_505272391c7af6bff7c59bcc6e21cb19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92e2f150258404d55715051c2e1f02a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2001-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76c559e88fac79229671891c31c583cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd5a32d85687779a7213040618e8b0c
publicationDate 2001-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0194944-A2
titleOfInvention Artificial antigen presenting cells and methods of use thereof
abstract The invention provides an artificial antigen presenting cell (AAPC) comprising a eukaryotic cell expressing an antigen presenting complex comprising a human leukocyte antigen (HLA) molecule of a single type, at least one exogenous accessory molecule and at least one exogenous T cell-specific epitope. Methods of use for activation of T lymphocytes are also provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2012829-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03006632-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1402064-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020120649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2012829-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004041849-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007105954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1402064-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03006632-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7319012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017079545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004042041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7973137-B1
priorityDate 2000-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0023053-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467532366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13013858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127866646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135763149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136084913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306

Total number of triples: 89.